BONESUPPORT HOLDING AB (BOEUF)
24.99
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
BONESUPPORT Total Assets (Quarterly) : 117.45M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 117.45M |
| December 31, 2025 | 112.72M |
| September 30, 2025 | 106.87M |
| June 30, 2025 | 101.33M |
| March 31, 2025 | 89.49M |
| December 31, 2024 | 79.91M |
| September 30, 2024 | 76.82M |
| June 30, 2024 | 71.07M |
| March 31, 2024 | 68.54M |
| December 31, 2023 | 68.35M |
| September 30, 2023 | 58.08M |
| June 30, 2023 | 34.83M |
| March 31, 2023 | 36.31M |
| December 31, 2022 | 35.68M |
| September 30, 2022 | 33.31M |
| June 30, 2022 | 30.94M |
| March 31, 2022 | 35.63M |
| December 31, 2021 | 37.99M |
| September 30, 2021 | 39.17M |
| June 30, 2021 | 48.99M |
| March 31, 2021 | 50.94M |
| Date | Value |
|---|---|
| December 31, 2020 | 56.65M |
| September 30, 2020 | 54.02M |
| June 30, 2020 | 53.26M |
| March 31, 2020 | 17.11M |
| December 31, 2019 | 20.97M |
| September 30, 2019 | 23.36M |
| June 30, 2019 | 28.31M |
| March 31, 2019 | 32.71M |
| December 31, 2018 | 36.79M |
| September 30, 2018 | 41.39M |
| June 30, 2018 | 47.35M |
| March 31, 2018 | 55.25M |
| December 31, 2017 | 72.88M |
| September 30, 2017 | 78.12M |
| June 30, 2017 | 72.77M |
| March 31, 2017 | 17.61M |
| December 31, 2016 | 20.78M |
| September 30, 2016 | 13.64M |
| June 30, 2016 | 9.416M |
| March 31, 2016 | 11.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioInvent International AB | 56.16M |
| Hansa Biopharma AB | 122.00M |
| BioArctic AB | 281.25M |
| Swedish Orphan Biovitrum AB | 8.530B |
| Diamyd Medical AB | 28.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.89M |
| Shareholders Equity (Quarterly) | 98.56M |
| Debt to Equity Ratio | 0.015 |
| Current Ratio | 5.132 |
| Net Debt Paydown Yield | -0.00% |